Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Supply Chain

Manufacture Advanced Medicine

Cell and Gene Champions Speak Up

| Angus Stewart

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

Business & Regulation Standards & Regulation

Why Only a Collective Approach Can Beat Fake Medicine

| Géraldine Lissalde-Bonnet | 5 min read

Substandard and falsified medicines are a global threat, but a collective pushback can beat them

Business & Regulation Trends & Forecasts

Video Roundtable: Pharma Trends & Events Post-COVID-19

Watch our special roundtable to learn about pharma industry trends and events post-COVID-19.

Business & Regulation Supply Chain

The Dual Sourcing Approach

| Sponsored by PCI

How robust is your strategy? Are you prepared for supply chain interruption?

Business & Regulation Digital Technologies

The Big Question: Can Pharma Truly Be Remodelled with AI?

| Maryam Mahdi | 2 min read

AI’s role in pharma operations and process is growing. But does it have the power to transform the industry?

Business & Regulation Supply Chain

Cell and Gene Champions 4

| Angus Stewart | 6 min read

We asked the field’s greatest minds: “What improvements do we need to see in cell and gene supply chains?”

Manufacture Contract Manufacturing Services

Adversity, Adaption, Delivery, Expansion

| Sponsored by PCI | 8 min read

How one CDMO navigated the pandemic and came out on top of industry trends

Business & Regulation Standards & Regulation

Acting on the Drug Supply Chain Security Act

| Shabbir Imber Safdar | 8 min read

The US drug supply chain is not immune to counterfeits – but there’s a law for that. Here’s how it has been used so far.

Business & Regulation COVID-19

VIDEO: From Quality Control to Cold Chain

| Sponsored by Dätwyler

The world wasn’t ready for COVID-19. But if we learn the right lessons, next time next time we’ll do better.

Manufacture Bioprocessing - Upstream & Downstream

Securing Supply: Best Practices for Critical Raw Materials

| Michelle Ferreri | 6 min read

COVID-19 has taught us that unexpected events can cause significant supply chain disruption, so pharma must be prepared.


Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register